Latest Videos

In this interview, Marcus Walker and Matthew Donora from Open Cell, a collaborative lab facility based in London's Shepherd's Bush, discuss how they plan to help increase the UK's COVID-19 testing capacity by tens of thousands of tests per day.

In a time where the shops are getting emptied at a rapid rate, Technology Networks science writer Ruairi J Mackenzie uses an easily available resource to explain how immunity can slow the spread of a virus through a population.

Our cultures give us a lot of advice about how to find happiness. Science, however, suggests that much of that advice just isn‘t right...

Dan Gilbert, author of Stumbling on Happiness, challenges the idea that we'll be miserable if we don't get what we want. Our "psychological immune system" lets us feel truly happy even when things don't go as planned.

This is everything you need to know for when a virus becomes a pandemic.

Neuroscientist Naznin Virji-Babul explains the science behind concussions and why they can be so dangerous.

This plenary from Technology Networks’ online symposium, Advances in Alzheimer’s Research, features Alzheimer’s genetics expert John Hardy discussing his influential work.

In this plenary from Technology networks online symposium, Advances in Alzheimer’s Research, Eliezer Masliah, director of the Division of Neuroscience at the National Institute on Aging (NIA), will outline the primary goals of the US federal effort against Alzheimer’s known as the National Alzheimer’s Project Act.

In this plenary from Technology Networks’ online symposium, Advances in Alzheimer’s Research, Prof Giovanna Mallucci will explain how studying the unfolded protein response (UPR) pathway has led her lab to the brink of clinical trials for dementia using repurposed drugs.

In this plenary from Technology Networks’ online symposium, Advances in Alzheimer’s Research, Professor Michal Schwartz will outline how her team have investigated the potential of immunotherapy in Alzheimer’s disease over the last twenty years.